1.	Phase III Cross-Over Immunotherapy with Polymerized Tumor Antigen-Adjuvant vs Progesterone for Advanced Renal Cancer Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: OSU-7902
2.	PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) Phase: Phase III Type: Treatment Status: Closed Age: 18 to 48 Sponsor: Pharmaceutical / Industry Protocol IDs: PGL09-027, NCT01252069
3.	Phase II Study of High-Dose Intravenous Progesterone and Doxorubicin for Progressive Endometrial Carcinoma Resistant to Ongoing Doxorubicin Alone (Summary Last Modified 09/97) Phase: Phase II Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: GOG-166
4.	Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II Phase: Phase II Type: Treatment Status: Completed Age: 18 to 60 Sponsor: Other Protocol IDs: UFK-HEF 4, NCT00247169
5.	Relation of Progestin Receptor Concentration to Efficacy of Progestin Therapy for Endometrial Adenocarcinoma - Pilot Study Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: GOG-P12
6.	Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer Phase: No phase specified Type: Supportive care Status: Closed Age: Postmenopausal Sponsor: Other Protocol IDs: CDR0000355122, CRUK-HRT, EU-20112, ISRCTN29941643, NCT00079248